Tj. Smith et al., N-BUTYRATE INDUCES PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 MESSENGER-RNA IN CULTURED HEP G2 CELLS, Hepatology, 23(4), 1996, pp. 866-871
n-Butyrate, a short-chain aliphatic carboxylic acid with pleiotropic a
ctions, is present at high concentrations in the portal circulation an
d thus may play an important role in the regulation of specific gene e
xpression in the mammalian Liver. We report here that n-butyrate can i
ncrease substantially the level of plasminogen activator inhibitor typ
e 1 (PAI-1) messenger RNA (mRNA) in Rep G2 cells, up to eightfold abov
e control cultures. Maximal effects occurred at a concentration of 3 m
mol/L n-butyrate and with a treatment period of 8 to 12 hours. Increas
es in PAI-1 mRNA were accompanied by modest increases (twofold) in the
encoded protein as assessed by specific enzyme-linked immunosorbent a
ssay and by [S-35]methionine incorporation into immunoprecipitable PAI
-1 in the culture medium. Nuclear run on studies showed that the rate
of transcription of the PAI-1 gene did not appear altered by treatment
with 3 mmol/L n-butyrate for 6 hours. The increases in steady-state P
AI-1 mRNA caused by exposure to n-butyrate can be blocked by cyclohexi
mide. Enhanced stability of mature PAI-1 transcript could not be demon
strated in Rep G2 cells treated with the carboxylic acid. We have repo
rted previously that n-butyrate can reduce the level of beta-galactosi
de alpha 2,6-sialyltransferase expression in Hep G2 cells. That effect
was attenuated with inhibitors of protein and RNA synthesis and was m
ediated at the posttranscriptional level. Thus, n-butyrate can influen
ce the expression of multiple genes in this hepatoblastoma cell throug
h its actions on events that appear to be posttranscriptional. These o
bservations may be relevant to the normal physiology of the mammalian
Liver because of the high concentrations of n-butyrate and related com
pounds to which the organ is ordinarily exposed.